# Losartan for Improved Vascular Endothelial Function After Preeclampsia

> **NCT04632589** · EARLY_PHASE1 · COMPLETED · sponsor: **Anna Stanhewicz, PhD** · enrollment: 11 (actual)

## Conditions studied

- Preeclampsia Postpartum

## Interventions

- **DRUG:** Losartan Potassium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04632589
- **Lead sponsor:** Anna Stanhewicz, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-22
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-03-13
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04632589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04632589, "Losartan for Improved Vascular Endothelial Function After Preeclampsia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04632589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*